nach oben

Archives of Virology

Erschienen in:

01.10.2009 | Original Article

Molecular characterisation and recent evolution of myxoma virus in Spain

verfasst von: Fernando Alda, Tania Gaitero, Mónica Suárez, Ignacio Doadrio

Erschienen in: Archives of Virology | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Myxoma virus and the European rabbit are one of the best-studied examples of coevolution of pathogen virulence and host resistance. Since the introduction of the virus in Spain in 1953, a decrease in its virulence has been observed; however, most strains are still considered highly virulent. To determine whether this attenuation is due to molecular differences, and to characterise the field strains in Spain and the genetic changes that have occurred since the introduction of the virus, we analysed 7,741 bp in 97 virus samples from 12 localities. We found an extremely low genetic variability and an absence of a geographic structure. We defined 35 haplotypes, none of which were identical to the original Lausanne strain. Three genetic groups were determined and were found to occur at different frequencies in different locations. Overall, virus evolution deviated from neutrality and did not conform to a strict molecular clock, probably due to the existence of a strong selective pressure that acts differently across the viral genome.

Nur mit Berechtigung zugänglich

Abrantes J, Esteves PJ, Carmo CR, Müller A, Thompson G, van der Loo W (2008) Genetic characterization of the chemokine receptor CXCR4 gene in lagomorphs: comparison between the families Ochotonidae and Leporidae. Int J Immunogenet 35:111–117PubMedCrossRef

Alda F, Gaitero T, Alcaraz L, Zardoya R, Doadrio I, Suárez M (2007) Coevolución de los virus de la mixomatosis y de la enfermedad hemorrágica con el conejo (Oryctolagus cuniculus L., 1758) en la Península Ibérica. In: Ramírez L, Asensio B (eds) Proyectos de investigación en parques nacionales: 2003–2006. Organismo Autónomo de Parques Nacionales, Ministerio de Medio Ambiente, Madrid

Anderson RM, May RM (1982) Coevolution of hosts and parasites. Parasitology 85:411–426PubMedCrossRef

Babkin IV, Shchelkunov SN (2006) Time scale of poxvirus evolution. Mol Biol 40:16–19CrossRef

Bandelt HJ, Forster P, Rohl A (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16:37–48PubMed

Bárcena J, Pagès-Manté A, March R, Morales M, Ramírez MA, Sánchez-Vizcaíno JM, Torres JM (2000) Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates. Arch Virol 145:759–771PubMedCrossRef

Best SM, Collins SV, Kerr PJ (2000) Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Virology 277:76–91PubMedCrossRef

Best SM, Kerr PJ (2000) Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 267:36–48PubMedCrossRef

Cameron C, Hota-Mitchell S, Chen L, Barrett J, Cao JX, Macaulay C, Willer D, Evans D, McFadden G (1999) The complete DNA sequence of myxoma virus. Virology 264:298–318PubMedCrossRef

10.

Camus-Bouclainville C, Fiette L, Bouchiha S, Pignolet B, Counor D, Filipe C, Gelfi J, Messud-Petit F (2004) A virulence factor of myxoma virus colocalized with NF-κB in the nucleus and interferes with inflammation. J Virol 78:2510–2516PubMedCrossRef

11.

Castelloe J, Templeton AR (1994) Root probabilities for intraspecific gene trees under the neutral coalescent theory. Mol Phylogenet Evol 3:102–113PubMedCrossRef

12.

Corander J, Marttinen P, Sirén J, Tang J (2006) BAPS: Bayesian analysis of population structure, manual v, 4.1

13.

Corander J, Tang J (2007) Bayesian analysis of population structure based on linked molecular information. Math Biosci 205:19–31PubMedCrossRef

14.

Delibes-Mateos M, Ramírez E, Ferreras P, Villafuerte R (2008) Translocations as a risk for the conservation of European wild rabbit Oryctolagus cuniculus lineages. Oryx 42:259–264CrossRef

15.

Drake JW (1991) A constant rate of spontaneous mutation in DNA-based microbes. Proc Natl Acad Sci USA 88:7160–7164PubMedCrossRef

16.

Drake JW, Charlesworth B, Charlesworth D, Crow JF (1998) Rates of spontaneous mutation. Genetics 148:1667–1686PubMed

17.

Drummond AJ, Pybus OG, Rambaut A, Forsberg R, Rodrigo AG (2003) Measurably evolving populations. Trends Ecol Evol 18:481–488CrossRef

18.

Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214PubMedCrossRef

19.

Duffy S, Shackelton LA, Holmes EC (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9:267–276PubMedCrossRef

20.

Fenner F, Marshall ID (1955) Occurrence of attenuated strains of Myxoma virus in Europe. Nature 176:782–783PubMedCrossRef

21.

Fenner F, Marshall ID (1957) A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J Hyg 55:149–191CrossRef

22.

Fenner F, Ratcliffe FN (1965) Myxomatosis. Cambridge University Press, Cambridge

23.

Fenner F (1976) Classification and nomenclature of viruses. Second report of the International Committee on Taxonomy of Viruses. Intervirology 7:1–116PubMedCrossRef

24.

Fenner F (1983) Biological control as exemplified by smallpox eradication and myxomatosis. Proc R Soc Lond B 218:259–285PubMedCrossRef

25.

Fenner F, Fantini B (1999) Biological control of vertebrate pests: the history of myxomatosis; an experiment in evolution, 1st edn. CABI, Wallingford

26.

Fu YX, Li WH (1993) Maximum likelihood estimation of population parameters. Genetics 134:1261–1270PubMed

27.

Fu YX (1997) Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics 147:915–925PubMed

28.

Futuyma DJ (1998) Evolutionary Biology. Sinauer Associates, Sunderland

29.

Gubser C, Hue S, Kellam P, Smith GL (2004) Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85:105–117PubMedCrossRef

30.

Guerin JL, Gelfi J, Camus C, Delverdier M, Whisstock JC, Amardeihl MF, Py R, Bertagnoli S, Messud-Petit F (2001) Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence. J Gen Virol 82:1407–1417PubMed

31.

Harpending HC (1994) Signature of ancient population-growth in a low-resolution mitochondrial-DNA mismatch distribution. Hum Biol 66:591–600PubMed

32.

Holmes EC (2004) The phylogeography of human viruses. Mol Ecol 13:745–756PubMedCrossRef

33.

Johnston JB, McFadden G (2003) Poxvirus immunomodulatory strategies: current perspectives. J Virol 77:6093–6100PubMedCrossRef

34.

Kass RE, Raftery AE (1995) Bayes Factors. J Am Stat Assoc 90:773–795CrossRef

35.

Kerr P, McFadden G (2002) Immune responses to myxoma virus. Viral Immunol 15:229–246PubMedCrossRef

36.

Kerr PJ, Best SM (1998) Myxoma virus in rabbits. Rev Sci Tech 17:256–268PubMed

37.

Kosakovsky Pond SL, Frost SD (2005) Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22:1208–1222PubMedCrossRef

38.

Kosakovsky Pond SL, Frost SD (2005) Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21:2531–2533CrossRef

39.

Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD (2006) GARD: a genetic algorithm for recombination detection. Bioinformatics 22:3096–3098PubMedCrossRef

40.

Kottaridi C, Nomikou K, Teodori L, Savini G, Lelli R, Markoulatos P, Mangana O (2006) Phylogenetic correlation of Greek and Italian orf virus isolates based on VIR gene. Vet Microbiol 116:310–316PubMedCrossRef

41.

Labudovic A, Perkins H, van Leeuwen B, Kerr P (2004) Sequence mapping of the Californian MSW strain of Myxoma virus. Arch Virol 149:553–570PubMedCrossRef

42.

Lefkowitz EJ, Wang C, Upton C (2006) Poxviruses: past, present and future. Virus Res 117:105–118PubMedCrossRef

43.

Marshall ID, Fenner F (1958) Studies in the epidemiology of infectious myxomatosis of rabbits. V. Changes in the innate resitance of Australian wild rabbits exposed to myxomatosis. J Hyg 56:288–302CrossRef

44.

Marshall ID, Fenner F (1960) Studies in the epidemiology of infectious myxomatosis of rabbits. VII. The virulence of strains of myxoma virus recovered from Australian wild rabbits between 1951 and 1959. J Hyg 58:485–488CrossRef

45.

Marshall ID, Douglas GW (1961) Studies in the epidemiology of infectious myxomatosis of rabbits. VIII. Further observation on changes in the innate resistance of Australian wild rabbits exposed to myxomatosis. J Hyg 59:117–122CrossRef

46.

Mercer AA, Ueda N, Friederechs SM, Hofmann K, Fraser KM, Bateman T, Fleming SB (2006) Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation. Virus Res 116:146–158PubMed

47.

Messud-Petit F, Gelfi J, Delverdier M, Amardeihl MF, Py R, Sutter G, Bertagnoli S (1998) Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J Virol 72:7830–7839PubMed

48.

Morales M, Ramírez MA, Cano MJ, Párraga M, Castilla J, Pérez-Ordoyo LI, Torres JM, Bárcena J (2009) Genome comparison of a nonpathogenic Myxoma virus field strain with its ancestor, the virulent Lausanne strain. J Virol 83:2397–2403PubMedCrossRef

49.

Muñoz G (1960) Anverso y reverso de la mixomatosis. Servico Nacional de Pesca Fluvial y Caza, Madrid

50.

Nash P, Barrett JW, Cao JX, Hota-Michell S, Lalani LS, Everett H, Xu XM, Robichaud J, Hnatiuk S, Ainslie C, Seet BT, McFadden G (1999) Immunomodulation by viruses: the myxoma virus story. Immunol Rev 168:103–120PubMedCrossRef

51.

Newton MA, Raftery AE (1994) Approximate Bayesian inference with the weighted likelihood bootstrap (with discussion). J Roy Stat Soc B 56:3–48

52.

Osacar-Jimenez JJ, Lucientes-Curdi J, Calvete-Margolles C (2001) Abiotic factors influencing the ecology of wild rabbit fleas in north-eastern Spain. Med Vet Entomol 15:157–166PubMedCrossRef

53.

Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817–818PubMedCrossRef

54.

Posada D, Crandall KA (2001) Intraspecific gene genealogies: trees grafting into networks. Trends Ecol Evol 16:37–45PubMedCrossRef

55.

Psikal I, Smíd B, Rodák L, Valícek L, Bendová J (2003) Atypical myxomatosis - Virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate. J Vet Med B Infect Dis Vet Public Health 50:259–264PubMed

56.

Rambaut A, Drummond A (2007) Tracer v1.4. (http://beast.bio.ed.ac.uk/Tracer)

57.

Ramos-Onsins SE, Rozas J (2002) Statistical properties of new neutrality tests against population growth. Mol Biol Evol 19:2092–2100PubMed

58.

Ratcliffe FN, Myers N, Fennessy BV, Calaby JH (1952) Myxomatosis in Australia. A step forwards the biological control of the rabbit. Nature 170:1–13CrossRef

59.

Roff DA (1997) Evolutionary Quantitative Genetics. Chapman & Hall, New York

60.

Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R (2003) DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496–2497PubMedCrossRef

61.

Russell RJ, Robbins SJ (1989) Cloning and molecular characterization of the myxoma virus genome. Virology 170:147–159PubMedCrossRef

62.

Saint KM, French N, Kerr P (2001) Genetic variation in Australian isolates of myxoma virus: an evolutionary and epidemiological study. Arch Virol 146:1105–1123PubMedCrossRef

63.

Sakaoka H, Kurita K, Iida Y, Takada S, Umene K, Kim YT, Ren CS, Nahmias AJ (1994) Quantitative analysis of genomic polymorphism of herpes simplex virus type I strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol 75:513–527PubMedCrossRef

64.

Slatkin M, Hudson RR (1991) Pairwise comparisons of mitochondrial-DNA sequences in stable and exponentially growing populations. Genetics 129:555–562PubMed

65.

Swofford DL (1998) PAUP*: phylogenetic analysis using parsimony (*and other methods). Sinauer Associates, Sunderland, MA

66.

Tajima F (1989) Statistical-method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585–595PubMed

67.

Thiel T, Whiteman NK, Tirapé A, Baquero MI, Cedeño V, Walsh T, Jiménez Uzcátegui G, Parker PG (2005) Characterization of Canarypox-like viruses infecting endemic birds in the Galápagos Islands. J Wildl Dis 41:342–353PubMed

68.

Vilcek J (2004) Why are rabbits uniquely sensitive to myxoma virus? Cherchez l’interferon!. Nat Immunol 5:1205–1206PubMedCrossRef

69.

Weli SC, Traavik T, Tryland M, Coucheron DH, Nilssen O (2004) Analysis and comparison of the 4b core protein gene of avipoxviruses from wild birds: evidence for interspecies spatial phylogenetic variation. Arch Virol 149:2035–2046PubMed

70.

Williams K, Parer I, Coman B, Burley J, Braysher M (1995) Managing vertebrate pests: rabbits. Bureau of resource sciences/CSIRO Division of wildlife and ecology. Australian Government Publishing Services, Canberra

71.

Zuñiga MC (2002) A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation. Virus Res 88:17–33PubMedCrossRef

Titel: Molecular characterisation and recent evolution of myxoma virus in Spain
verfasst von: Fernando Alda
Tania Gaitero
Mónica Suárez
Ignacio Doadrio
Publikationsdatum: 01.10.2009
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 10/2009
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-009-0494-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2009

HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A

Comparison of the activities of BM2 protein and its H19 and W23 mutants of influenza B virus with activities of M2 protein and its H37 and W41 mutants of influenza A virus

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection

Insertion of large amino acid repeats and point mutations contribute to a high degree of sequence diversity in the X4 protein of tomato ringspot virus (genus Nepovirus)

Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates